Heparin pentasaccharide

• UNSPSC Description:

  Heparin pentasaccharide (Fondaparinux) is a chemically synthesized selective factor Xa inhibitor with anticoagulant activity. Heparin pentasaccharide can be utilized in researches related to venous thromboembolic events[1].

• Target Antigen:

  Factor Xa

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/heparin-pentasaccharide.html

• Smiles:

  O=S(O[C@H]([C@H]([C@H](O[C@@H]1COS(=O)(O)=O)O[C@@H]2[C@@H](O[C@H]([C@@H]([C@H]2O)OS(=O)(O)=O)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)NS(=O)(O)=O)OC)COS(=O)(O)=O)C(O)=O)NS(=O)(O)=O)[C@@H]1O[C@@H]4O[C@@H]([C@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(O)=O)O)O)NS(=O)(O)=O)C(O)=O)(O)=O

• Molecular Weight:

  1508.26

• References & Citations:

  [1]Bauersachs RM, et al. Fondaparinux Sodium: Recent Advances in the Management of Thrombosis. J Cardiovasc Pharmacol Ther. 2023 Jan-Dec;28:10742484221145010.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  104993-28-4